Product Information
CEFDINIR 250 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1195 per ML under NDC 68180072304. Its NADAC has been published 315 times since Aug 12, 2020.
FDA first approved this application on May 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180072304
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065259FDA Approved
5/31/2006
TE Code
AB
On Market Since
5/7/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 250 MG/5 ML SUSP has been published 315 times since Aug 12, 2020, and over the history we have for it it has declined 34.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1195 per ML |
|---|---|
| All-time high | $0.2347 (Apr 12, 2023) |
| All-time low | $0.1148 (Nov 20, 2024) |
| 52-week high | $0.1412 |
| 52-week low | $0.1195 |
| Median price | $0.1608 |
| Average price | $0.1573 |
| Largest weekly change | +39.7% (Feb 1, 2023) |
| Weeks tracked | 315 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFDINIR 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 250 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.1195 per ML (NDC 68180072304), effective Aug 19, 2026.
How has the price of CEFDINIR 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 250 MG/5 ML SUSP has declined 34.0%. It has been tracked across 315 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for CEFDINIR 250 MG/5 ML SUSP?
Since Aug 12, 2020, the NADAC for CEFDINIR 250 MG/5 ML SUSP has ranged from a low of $0.1148 (Nov 20, 2024) to a high of $0.2347 (Apr 12, 2023), with a median of $0.1608 per ML.
Are there cheaper alternatives to CEFDINIR 250 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFDINIR 250 MG/5 ML SUSP, is $0.1135 per ML — about 5% below CEFDINIR 250 MG/5 ML SUSP.
Who manufactures CEFDINIR 250 MG/5 ML SUSP?
CEFDINIR 250 MG/5 ML SUSP (NDC 68180072304) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.